These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 776138)

  • 1. Adriamycin heart disease.
    Ewy GA; Jones S; Groves BM
    Ariz Med; 1976 Apr; 33(4):274-8. PubMed ID: 776138
    [No Abstract]   [Full Text] [Related]  

  • 2. [Is the use of adriamycin (doxorubicin) limited by its cardiotoxicity?].
    Reinhardt D; Hofmann V; Martz G
    Schweiz Med Wochenschr; 1985 Apr; 115(16):557-61. PubMed ID: 4001904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adriamycin-induced cardiotoxicity (cardiomyopathy and congestive heart failure) in rats.
    Mettler FP; Young DM; Ward JM
    Cancer Res; 1977 Aug; 37(8 Pt 1):2705-13. PubMed ID: 872096
    [No Abstract]   [Full Text] [Related]  

  • 4. Doxorubicin (Adriamycin) cardiotoxicity.
    Weisburst MR; Pearlman ES; Capone RJ
    Conn Med; 1980 Mar; 44(3):133-6. PubMed ID: 7363615
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cardiotoxicity of doxorubicin in children].
    Pilon JW; Naeff MS; Taminiau JA
    Ned Tijdschr Geneeskd; 1984 Jul; 128(28):1339-43. PubMed ID: 6482993
    [No Abstract]   [Full Text] [Related]  

  • 6. Adriamycin and the heart.
    Henderson IC; Frei TE
    N Engl J Med; 1979 Feb; 300(6):310-2. PubMed ID: 759884
    [No Abstract]   [Full Text] [Related]  

  • 7. Doxorubicin in experimental and clinical heart failure.
    Christiansen S; Autschbach R
    Eur J Cardiothorac Surg; 2006 Oct; 30(4):611-6. PubMed ID: 16901709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of doxorubicin-induced congestive heart failure by continuous intravenous infusion in multiple myeloma; a case report and review of the literature.
    Lieverse RJ; Ossenkoppele GJ
    Neth J Med; 1991 Feb; 38(1-2):33-4. PubMed ID: 2030807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiotoxicity of epirubicin versus doxorubicin: cost and clinical results.
    Ventura GJ
    J Clin Oncol; 2005 Apr; 23(12):2873; author reply 2873-4. PubMed ID: 15838014
    [No Abstract]   [Full Text] [Related]  

  • 10. Adriamycin given as a weekly schedule without a loading course: clinically effective with reduced incidence of cardiotoxicity.
    Chlebowski RT; Paroly WS; Pugh RP; Hueser J; Jacobs EM; Pajak TF; Bateman JR
    Cancer Treat Rep; 1980 Jan; 64(1):47-51. PubMed ID: 7379058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polycardiographic evaluation of the cardiotoxicity of adriamycin].
    Villani F; Beretta G; Guindani A; Pagnoni A; Vivarelli S
    G Ital Chemioter; 1975; 22(1-2):39-46. PubMed ID: 1235351
    [No Abstract]   [Full Text] [Related]  

  • 12. Noninvasive monitoring of adriamycin cardiotoxicity by "Sphygmo-Recording" of the pulse wave delay (QKd interval).
    Greco FA; Brereton HD; Rodbard D
    Cancer Treat Rep; 1976 Sep; 60(9):1239-45. PubMed ID: 797446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How adriamycin affects the heart.
    Ewy GA
    Med Times; 1978 Aug; 106(8):36-42. PubMed ID: 682892
    [No Abstract]   [Full Text] [Related]  

  • 14. Partial left ventriculectomy in patients with neoplasms and severe heart failure who are not candidates for cardiac transplantation.
    Christiansen S
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):302-3. PubMed ID: 14752460
    [No Abstract]   [Full Text] [Related]  

  • 15. [Adriamycin cardiomyopathy].
    Nilles M; Wehr M; Köhler F
    Med Welt; 1984 Jan; 35(4):103-8. PubMed ID: 6700420
    [No Abstract]   [Full Text] [Related]  

  • 16. Adriamycin cardiotoxicity in stage IV breast cancer: possible enhancement with prior left chest radiation therapy.
    Kinsella TJ; Ahmann DL; Giuliani ER; Lie JT
    Int J Radiat Oncol Biol Phys; 1979; 5(11-12):1997-2002. PubMed ID: 397210
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytokines are not upregulated in adriamycin-induced cardiomyopathy and heart failure.
    Lou H; Danelisen I; Singal PK
    J Mol Cell Cardiol; 2004 May; 36(5):683-90. PubMed ID: 15135663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adriamycin cardiotoxicity in man.
    Rinehart JJ; Lewis RP; Balcerzak SP
    Ann Intern Med; 1974 Oct; 81(4):475-8. PubMed ID: 4277990
    [No Abstract]   [Full Text] [Related]  

  • 19. Delayed cardiac toxicity from anthracycline therapy.
    Steinherz L; Steinherz P
    Pediatrician; 1991; 18(1):49-52. PubMed ID: 1983861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinicopathologic analysis of adriamycin cardiotoxicity.
    Lefrak EA; Pitha J; Rosenheim S; Gottlieb JA
    Cancer; 1973 Aug; 32(2):302-14. PubMed ID: 4353012
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.